U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Details

Stereochemistry ABSOLUTE
Molecular Formula C16H17NO4
Molecular Weight 287.3105
Optical Activity UNSPECIFIED
Defined Stereocenters 4 / 4
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of LYCORINE

SMILES

O[C@H]1C=C2CCN3CC4=CC5=C(OCO5)C=C4[C@@H]([C@@H]23)[C@@H]1O

InChI

InChIKey=XGVJWXAYKUHDOO-DANNLKNASA-N
InChI=1S/C16H17NO4/c18-11-3-8-1-2-17-6-9-4-12-13(21-7-20-12)5-10(9)14(15(8)17)16(11)19/h3-5,11,14-16,18-19H,1-2,6-7H2/t11-,14-,15+,16+/m0/s1

HIDE SMILES / InChI

Description

Lycorine is a natural pyrrolo[de]phenanthridine ring-type alkaloid extracted from Amaryllidaceae. It has been reported to exhibit a wide range of physiological effects, including anti-viral, anti-malarial, anti-cancer and anti-inflammatory. Although a defined target or mechanism of action of lycorine is still unknown, it is a candidate anti-inflammatory and anti-cancer drug.

CNS Activity

Approval Year

Targets

Primary TargetPharmacologyConditionPotency
213.0 µM [IC50]

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Unknown
Primary
Unknown

PubMed

Sample Use Guides

In Vivo Use Guide
In a preclinical study, mice were given lycorine at 5 mg/kg/day or 10 mg/kg/day.
Route of Administration: Intraperitoneal
In Vitro Use Guide
In a cell viability assay, PC-3M, LNCaP, 22RV1, DU145 and PNT1A cells were treated with various concentrations of lycorine (0, 0.05, 0.1, 1, 5, 10, 20, 50 and 100 uM) for 48 hours.